Lippis Daniel J.

CVP, TAVREdwards Lifesciences Corp (EW) · full profile →Form 4 · filed May 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$170K
Net Open-Market Flow
-$170K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)1K$59.26$60K35K
May 4, 2026Sell(S)1K$83.98$86K34K
May 3, 2026Tax withholding(F)252$83.98$21K34K
May 1, 2026Option exercise(M)1K$59.26$60K35K
May 1, 2026Sell(S)19$83.99$2K35K
May 1, 2026Sell(S)1K$82.99$83K34K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)1K$00
May 1, 2026Option exercise(M)1K$01K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-004909) within minutes of acceptance. Every field above traces to the original document. Verify it directly: